Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Filings today ..

View:

Post by Mole101 on Jan 15, 2021 8:19pm

Filings today ..

Filings by transaction date

Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Wilson, Alain

Ownership Type:

Control or Direction

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

124,700

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Wallace, John Lawrence

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

484,200

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Vaughan, David James

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

102,700

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Stauffer, Joseph

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

70,000

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Macnee, Walter Minnes

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

40,000

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Legault, Daniel Marcel

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

513,200

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Khouri, Amal

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

40,000

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Flower, Roderick John

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

40,000

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Curtis, Scott Wilson

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

102,700

Price:

--
Jan 11, 2021 (filed on Jan 15, 2021)

Insider Name:

Batal, Rami

Ownership Type:

Direct Ownership

Securities:

Restricted Share Units

Nature of Transaction:

56 - Grant of rights

# or value acquired/disposed of:

64,500

342

Comment

Comment by Pandora on Jan 15, 2021 8:57pm

For whatever reason I find this easier to read: As of 11:59pm ET January 15th, 2021 Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price Jan 15/21 Jan 11/21 Wilson, Alain Control or Direction Restricted ...more

321

Comment

Antibe Therapeutics Inc(Pre-Merger)